ORMP
Price
$2.13
Change
+$0.01 (+0.47%)
Updated
Apr 10 closing price
Capitalization
86.6M
47 days until earnings call
VERV
Price
$3.05
Change
-$0.36 (-10.56%)
Updated
Apr 10 closing price
Capitalization
272.16M
26 days until earnings call
Ad is loading...

ORMP vs VERV

Header iconORMP vs VERV Comparison
Open Charts ORMP vs VERVBanner chart's image
Oramed Pharmaceuticals
Price$2.13
Change+$0.01 (+0.47%)
Volume$53.68K
Capitalization86.6M
Verve Therapeutics
Price$3.05
Change-$0.36 (-10.56%)
Volume$1.96M
Capitalization272.16M
ORMP vs VERV Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VERV commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (ORMP: $2.13 vs. VERV: $3.05)
Brand notoriety: ORMP and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 18% vs. VERV: 129%
Market capitalization -- ORMP: $86.6M vs. VERV: $272.16M
ORMP [@Biotechnology] is valued at $86.6M. VERV’s [@Biotechnology] market capitalization is $272.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $263.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, both ORMP and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 6 bearish.
  • VERV’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VERV is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -1.39% price change this week, while VERV (@Biotechnology) price change was -20.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.33%. For the same industry, the average monthly price growth was -17.76%, and the average quarterly price growth was -19.66%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-7.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($272M) has a higher market cap than ORMP($86.6M). ORMP YTD gains are higher at: -11.983 vs. VERV (-45.922). ORMP has higher annual earnings (EBITDA): 9.44M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. ORMP (142M). ORMP has less debt than VERV: ORMP (429K) vs VERV (70M). VERV has higher revenues than ORMP: VERV (32.3M) vs ORMP (0).
ORMPVERVORMP / VERV
Capitalization86.6M272M32%
EBITDA9.44M-221.91M-4%
Gain YTD-11.983-45.92226%
P/E Ratio20.91N/A-
Revenue032.3M-
Total Cash142M524M27%
Total Debt429K70M1%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
37
SEASONALITY SCORE
1..100
25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVERV
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
75%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWYF0.03N/A
+8.70%
ARWAY CORP.
REPYY10.81-0.25
-2.26%
Repsol S.A.
NLCP12.66-0.33
-2.54%
NewLake Capital Partners, Inc.
DFKCY11.68-0.38
-3.15%
Daifuku Co., Ltd.
ADYYF1473.00-131.36
-8.19%
Adyen N.V.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.47%
BTAI - ORMP
44%
Loosely correlated
-8.38%
INO - ORMP
44%
Loosely correlated
-0.63%
MBIO - ORMP
44%
Loosely correlated
-1.47%
VERV - ORMP
44%
Loosely correlated
-10.56%
ZNTL - ORMP
43%
Loosely correlated
-3.42%
More